AbbVie Fights FTC Discovery Expansion In Pay-For-Delay Suit
AbbVie Inc. wants to nix the U.S. Federal Trade Commission's bid for expanded discovery in the pay-for-delay suit over testosterone drug AndroGel, arguing in Pennsylvania federal court Friday that expansion will...To view the full article, register now.
Already a subscriber? Click here to view full article